In the context of AD, the function of this crucial triage system is compromised, the overwhelming production of hyperphosphorylated tau may saturate the CHIP system, while the broader collapse of proteostasis or direct inhibitory effects of Aβ may impair CHIP's activity, allowing pathological tau to escape degradation and proceed down the aggregation cascade [499]. The gene discussed is MAPT; the disease is Alzheimer disease.